What’s new in primary ITP? Key updates from ASH 2024
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.
The experts
Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA
Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK
Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.